DLA
RXO icon

Douglas Lane & Associates’s RXO RXO Stock Holding History

Douglas Lane & Associates’s Portfolio RXO Stock Details RXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92.3M Sell
3,346,342
-160,184
-5% -$3.54M 1.25% 21
2026
Q1 		$51.3M Buy
3,506,526
+99,783
+3% +$1.46M 0.74% 57
2025
Q4 		$43.1M Sell
3,406,743
-459,262
-12% -$6.77M 0.59% 74
2025
Q3 		$59.5M Buy
3,866,005
+126,227
+3% +$2.03M 0.83% 45
2025
Q2 		$58.8M Buy
3,739,778
+148,738
+4% +$2.25M 0.85% 41
2025
Q1 		$68.6M Buy
3,591,040
+916,379
+34% +$20.1M 1.01% 34
2024
Q4 		$63.8M Buy
2,674,661
+2,881
+0.1% +$80.4K 0.9% 40
2024
Q3 		$74.8M Sell
2,671,780
-26,745
-1% -$755K 1.03% 33
2024
Q2 		$70.6M Buy
2,698,525
+52,378
+2% +$1.09M 1% 36
2024
Q1 		$57.9M Buy
2,646,147
+66,757
+3% +$1.43M 0.82% 51
2023
Q4 		$60M Buy
2,579,390
+248,883
+11% +$5.01M 0.92% 47
2023
Q3 		$46M Buy
2,330,507
+554,078
+31% +$10.9M 0.77% 51
2023
Q2 		$40.3M Buy
1,776,429
+838,811
+89% +$16.9M 0.65% 58
2023
Q1 		$18.4M Buy
937,618
+104,913
+13% +$2.01M 0.31% 96
2022
Q4 		$14.3M Buy
+832,705
New +$14.8M 0.24% 103

Other funds holding RXO

OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Douglas Lane & Associates's RXO Position: Q2 2026 in Review

Douglas Lane & Associates reduced its RXO (RXO) stake by 4.6% in Q2 2026, selling an estimated $3.54M and leaving 3,346,342 shares worth $92.3M. The position accounts for 1.25% of the portfolio, ranked #21.

Douglas Lane & Associates first reported a position in RXO in Q4 2022 and has held it in 15 quarters since. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Douglas Lane & Associates held 3,346,342 shares of RXO worth $92.3M as of Q2 2026.
  • Douglas Lane & Associates sold 160,184 RXO shares in Q2 2026, an estimated $3.54M.
  • RXO made up 1.25% of Douglas Lane & Associates's portfolio in Q2 2026, its #21 holding.
  • Douglas Lane & Associates first reported a position in RXO in Q4 2022 and has held it in 15 quarters since.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Douglas Lane & Associates's 13F filing for Q2 2026, filed 14 Jul 2026.